Founder and CEO @ Canopy Immuno-therapeutics
Kfir has over 15 years of combined industry and academic experience, leading interdisciplinary and multicultural teams combining Applied Immunology, Biochemistry, Engineering, Big Data, and Industrial Design, in multiple clinical applications. Kfir co-founded MeMed Dx and serves as its CTO and Chairman of the Board, where he led the development and clinical validation of the entire MeMed technology suite including the MeMed BV™ technology, and the MeMed Key™ Point of care platform, from an initial concept to development completion. He holds a B.A. in Biology (Summa Cum Laude), B.Sc. in Medicine (Magna Cum Laude), Ph.D. in Molecular Immunology, and 6 years training at the Technion-Institute of Technology School of Medicine. He is the co-author of 83 granted and pending patents, the author of 16 peer-reviewed publications, and the recipient of multiple research excellence awards, including the prestigious Gutwirth Excellence award and the Wolf Award for research students, and was listed as one of the top 25 voices in Precision Medicine for 2019.